143 related articles for article (PubMed ID: 38483586)
21. Biochemical recurrence after chemohormonal therapy followed by robot-assisted radical prostatectomy in very-high-risk prostate cancer patients.
Sugino F; Nakane K; Kawase M; Ueda S; Tomioka M; Takeuchi Y; Yamada T; Namiki S; Kumada N; Kawase K; Kato D; Takai M; Iinuma K; Tobisawa Y; Ito T; Koie T
J Robot Surg; 2023 Oct; 17(5):2441-2449. PubMed ID: 37466903
[TBL] [Abstract][Full Text] [Related]
22. Oncological outcomes after robot-assisted radical prostatectomy: long-term follow-up in 4803 patients.
Sukumar S; Rogers CG; Trinh QD; Sammon J; Sood A; Stricker H; Peabody JO; Menon M; Diaz-Insua M
BJU Int; 2014 Dec; 114(6):824-31. PubMed ID: 24053586
[TBL] [Abstract][Full Text] [Related]
23. Long-term cancer control outcomes in patients with clinically high-risk prostate cancer treated with robot-assisted radical prostatectomy: results from a multi-institutional study of 1100 patients.
Abdollah F; Sood A; Sammon JD; Hsu L; Beyer B; Moschini M; Gandaglia G; Rogers CG; Haese A; Montorsi F; Graefen M; Briganti A; Menon M
Eur Urol; 2015 Sep; 68(3):497-505. PubMed ID: 26119559
[TBL] [Abstract][Full Text] [Related]
24. Nomogram Predicting Locally Advanced Prostate Cancer in Patients with Clinically Organ-Confined Disease Who Underwent Robot-Assisted Radical Prostatectomy: A Retrospective Multicenter Cohort Study in Japan (The MSUG94 Group).
Kawase M; Goto T; Ebara S; Tatenuma T; Sasaki T; Ishihara T; Ikehata Y; Nakayama A; Toide M; Yoneda T; Sakaguchi K; Teishima J; Kobayashi T; Makiyama K; Inoue T; Kitamura H; Saito K; Koga F; Urakami S; Koie T
Ann Surg Oncol; 2023 Oct; 30(11):6925-6933. PubMed ID: 37338747
[TBL] [Abstract][Full Text] [Related]
25. Safety of robot-assisted radical prostatectomy in an Italian spoke hospital: Long-term oncologic and functional outcomes with median 11.3 years follow-up.
Fulcoli V; Bianco M; Sartor G; Agostini A; Costa G; Laurini L
Urologia; 2022 May; 89(2):248-256. PubMed ID: 35139712
[TBL] [Abstract][Full Text] [Related]
26. Impact of positive surgical margins on prostate-specific antigen failure after radical prostatectomy in adjuvant treatment-naïve patients.
Ploussard G; Agamy MA; Alenda O; Allory Y; Mouracade P; Vordos D; Hoznek A; Abbou CC; de la Taille A; Salomon L
BJU Int; 2011 Jun; 107(11):1748-54. PubMed ID: 20883488
[TBL] [Abstract][Full Text] [Related]
27. Prognostic differences among Grade Group 4 subgroups in robotic-assisted radical prostatectomy.
Sasaki T; Ebara S; Tatenuma T; Ikehata Y; Nakayama A; Kato D; Toide M; Yoneda T; Sakaguchi K; Teishima J; Makiyama K; Kitamura H; Saito K; Koie T; Koga F; Urakami S; Inoue T
BJUI Compass; 2022 Sep; 3(5):392-399. PubMed ID: 35950038
[TBL] [Abstract][Full Text] [Related]
28. The significance of micro-lymphatic invasion and pathological Gleason score in prostate cancer patients with pathologically organ-confined disease and negative surgical margins after robot-assisted radical prostatectomy.
Hashimoto T; Nakashima J; Inoue R; Komori O; Yamaguchi Y; Kashima T; Satake N; Nakagami Y; Namiki K; Nagao T; Ohno Y
Int J Clin Oncol; 2020 Feb; 25(2):377-383. PubMed ID: 31673831
[TBL] [Abstract][Full Text] [Related]
29. Clinical significance and risk factors of International Society of Urological Pathology (ISUP) grade upgrading in prostate cancer patients undergoing robot-assisted radical prostatectomy.
Takeshima Y; Yamada Y; Teshima T; Fujimura T; Kakutani S; Hakozaki Y; Kimura N; Akiyama Y; Sato Y; Kawai T; Yamada D; Kume H
BMC Cancer; 2021 May; 21(1):501. PubMed ID: 33947348
[TBL] [Abstract][Full Text] [Related]
30. Robot-Assisted Radical Prostatectomy for Potential Cancer Control in Patients with Metastatic Prostate Cancer.
Takagi K; Kawase M; Kato D; Kawase K; Takai M; Iinuma K; Nakane K; Hagiwara N; Yamada T; Tomioka M; Koie T
Curr Oncol; 2022 Apr; 29(4):2864-2870. PubMed ID: 35448207
[TBL] [Abstract][Full Text] [Related]
31. Safety of selective nerve sparing in high risk prostate cancer during robot-assisted radical prostatectomy.
Kumar A; Samavedi S; Bates AS; Mouraviev V; Coelho RF; Rocco B; Patel VR
J Robot Surg; 2017 Jun; 11(2):129-138. PubMed ID: 27435701
[TBL] [Abstract][Full Text] [Related]
32. No clinical significance of the time interval between biopsy and robotic-assisted radical prostatectomy for patients with clinically localized prostate cancer on biochemical recurrence: a propensity score matching analysis.
Hirasawa Y; Ohori M; Sugihara T; Hashimoto T; Satake N; Gondo T; Nakagami Y; Namiki K; Yoshioka K; Nakashima J; Tachibana M; Ohno Y
Jpn J Clin Oncol; 2017 Nov; 47(11):1083-1089. PubMed ID: 28973504
[TBL] [Abstract][Full Text] [Related]
33. Influence of pathological factors on oncological outcomes after robot-assisted radical prostatectomy for localized prostate cancer: Results of a prospective study.
Kozal S; Peyronnet B; Cattarino S; Seisen T; Comperat E; Vaessen C; Mozer P; Renard-Penna R; Cussenot O; Rouprêt M; Drouin SJ
Urol Oncol; 2015 Jul; 33(7):330.e1-7. PubMed ID: 25998747
[TBL] [Abstract][Full Text] [Related]
34. Positive surgical margins in radical prostatectomy patients do not predict long-term oncological outcomes: results from the Shared Equal Access Regional Cancer Hospital (SEARCH) cohort.
Mithal P; Howard LE; Aronson WJ; Terris MK; Cooperberg MR; Kane CJ; Amling C; Freedland SJ
BJU Int; 2016 Feb; 117(2):244-8. PubMed ID: 26010160
[TBL] [Abstract][Full Text] [Related]
35. Risk of biochemical recurrence based on extent and location of positive surgical margins after robot-assisted laparoscopic radical prostatectomy.
Marcq G; Michelet A; Hannink G; Rizk J; Sauvain J; Villers A; Saffarini M; Rochat CH
BMC Cancer; 2018 Dec; 18(1):1291. PubMed ID: 30587172
[TBL] [Abstract][Full Text] [Related]
36. Predictors of Recurrence After Metastasis-directed Therapy in Oligorecurrent Prostate Cancer Following Radical Prostatectomy.
Milenkovic U; Kuijk J; Roussel E; Devos G; Van den Broeck T; Van Eecke H; Vanderstichele A; Duvillier T; Verhamme L; Van Haute W; Goeman L; Berghen C; Joniau S; De Meerleer G
Eur Urol Oncol; 2023 Dec; 6(6):582-589. PubMed ID: 36878753
[TBL] [Abstract][Full Text] [Related]
37. The impact of prognostic group classification on prostate cancer progression in intermediate-risk patients according to the European Association of Urology system: results in 479 patients treated with robot-assisted radical prostatectomy at a single tertiary referral center.
Porcaro AB; Bianchi A; Panunzio A; Gallina S; Tafuri A; Serafin E; Orlando R; Mazzucato G; Vidiri S; D'Aietti D; Montanaro F; Marafioti Patuzzo G; Artoni F; Baielli A; Ditonno F; Rizzetto R; Veccia A; Gozzo A; De Marco V; Brunelli M; Cerruto MA; Antonelli A
Ther Adv Urol; 2024; 16():17562872241229260. PubMed ID: 38348129
[TBL] [Abstract][Full Text] [Related]
38. Robotic assisted laparoscopic prostatectomy versus radical retropubic prostatectomy for clinically localized prostate cancer: comparison of short-term biochemical recurrence-free survival.
Barocas DA; Salem S; Kordan Y; Herrell SD; Chang SS; Clark PE; Davis R; Baumgartner R; Phillips S; Cookson MS; Smith JA
J Urol; 2010 Mar; 183(3):990-6. PubMed ID: 20083261
[TBL] [Abstract][Full Text] [Related]
39. High Gleason grade carcinoma at a positive surgical margin predicts biochemical failure after radical prostatectomy and may guide adjuvant radiotherapy.
Savdie R; Horvath LG; Benito RP; Rasiah KK; Haynes AM; Chatfield M; Stricker PD; Turner JJ; Delprado W; Henshall SM; Sutherland RL; Kench JG
BJU Int; 2012 Jun; 109(12):1794-800. PubMed ID: 21992536
[TBL] [Abstract][Full Text] [Related]
40. Systematic review and meta-analysis of studies reporting oncologic outcome after robot-assisted radical prostatectomy.
Novara G; Ficarra V; Mocellin S; Ahlering TE; Carroll PR; Graefen M; Guazzoni G; Menon M; Patel VR; Shariat SF; Tewari AK; Van Poppel H; Zattoni F; Montorsi F; Mottrie A; Rosen RC; Wilson TG
Eur Urol; 2012 Sep; 62(3):382-404. PubMed ID: 22749851
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
